Earnings Feed
Sign Up
Home/Filings/4/0001209191-15-007291
4//SEC Filing

MEDTRONIC INC 4

Accession 0001209191-15-007291

CIK 0000064670operating
View on SEC.govCompany Profile

Filed

Jan 27, 7:00 PM ET

Accepted

Jan 28, 9:42 PM ET

Size

28.4 KB

Accession

0001209191-15-007291

Insider Transaction Report

Form 4
Period: 2015-01-26
MEDTRONIC INCMDT
ANDERSON RICHARD H
Director
Transactions
  • Disposition to Issuer

    Stock option (right to buy)

    2015-01-26−1,493→ 0 total
    Exercise: $46.91Exp: 2016-09-01→ Common stock (1,493 underlying)
  • Disposition to Issuer

    Stock option (right to buy)

    2015-01-26−2,671→ 0 total
    Exercise: $29.96Exp: 2019-04-27→ Common stock (2,671 underlying)
  • Disposition to Issuer

    Common stock

    2015-01-26−45,548.858→ 0 total
  • Disposition to Issuer

    Stock option (right to buy)

    2015-01-26−1,010→ 0 total
    Exercise: $52.84Exp: 2017-09-01→ Common stock (1,010 underlying)
  • Disposition to Issuer

    Stock option (right to buy)

    2015-01-26−1,590→ 0 total
    Exercise: $50.34Exp: 2018-04-28→ Common stock (1,590 underlying)
  • Disposition to Issuer

    Common stock

    2015-01-26−4,800→ 0 total(indirect: By Trust)
  • Disposition to Issuer

    Stock option (right to buy)

    2015-01-26−1,229→ 0 total
    Exercise: $56.99Exp: 2015-09-01→ Common stock (1,229 underlying)
  • Disposition to Issuer

    Stock option (right to buy)

    2015-01-26−1,813→ 0 total
    Exercise: $44.13Exp: 2020-05-03→ Common stock (1,813 underlying)
  • Disposition to Issuer

    Common stock

    2015-01-26−25→ 0 total(indirect: Cust/son)
  • Disposition to Issuer

    Common stock

    2015-01-26−2,480→ 0 total(indirect: By IRA)
  • Disposition to Issuer

    Stock option (right to buy)

    2015-01-26−4,211→ 0 total
    Exercise: $57.00Exp: 2015-08-31→ Common stock (4,211 underlying)
Footnotes (9)
  • [F1]Represents shares of Medtronic, Inc. ("Medtronic"), including deferred units credited under a Medtronic, Inc. equity-based plan to be paid in Medtronic, Inc. common stock upon the director's resignation or retirement as well as a balance increase of 228.915 shares since the director's last Form 4 filing due to exempt transactions such as dividend reinvestment, disposed of pursuant to the merger (the "Merger)of a wholly-owned subsidiary of Medtronic plc ("New Medtronic") with and into Medtronic, with Medtronic surviving as a wholly-owned subsidiary of New Medtronic, in exchange for ordinary shares of New Medtronic, which was consummated after and conditioned on New Medtronic's acquisition of Covidien plc, by means of a "scheme of arrangement", an Irish statutory procedure under the Companies Act of 1963. (Continued in Footnote 2)
  • [F2]At the effective time of the Merger, each Medtronic common share (including each deferred unit) was cancelled and converted into the right to receive one New Medtronic ordinary share. Under the terms of the Merger, the director received cash in lieu of fractional shares of New Medtronic and deferred units were rounded up to the nearest whole share.
  • [F3]This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 4,211 ordinary shares of New Medtronic for $57.00 per share with the same terms and conditions as the original Medtronic stock option.
  • [F4]This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,229 ordinary shares of New Medtronic for $56.99 per share with the same terms and conditions as the original Medtronic stock option.
  • [F5]This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,493 ordinary shares of New Medtronic for $46.91 per share with the same terms and conditions as the original Medtronic stock option.
  • [F6]This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,010 ordinary shares of New Medtronic for $52.84 per share with the same terms and conditions as the original Medtronic stock option.
  • [F7]This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,590 ordinary shares of New Medtronic for $50.34 per share with the same terms and conditions as the original Medtronic stock option.
  • [F8]This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 2,671 ordinary shares of New Medtronic for $29.96 per share with the same terms and conditions as the original Medtronic stock option.
  • [F9]This option, which was fully vested at the effective time of the Merger, was assumed by New Medtronic in the Merger and converted into an option to purchase 1,813 ordinary shares of New Medtronic for $44.13 per share with the same terms and conditions as the original Medtronic stock option.

Documents

1 file

Issuer

MEDTRONIC INC

CIK 0000064670

→
Entity typeoperating
IncorporatedMN

Related Parties

1
  • filerCIK 0000064670

Filing Metadata

Form type
4
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:42 PM ET
Size
28.4 KB
View on SEC.gov